Kidney transplant: Nov 16, 2022 ( donor kidney CMV+, recipient CMV-)
kidney (I’ve named Cindy): Doing very well (creatinine .81, eGFR 78)
Struggles: very low white blood cell count from Feb through July & CMV from May to date
CMV: 4 flare-ups to date
I was referred out to see an infectious disease specialist to help with CMV treatment about 3 months ago. She pulled me off Valcyte (antiviral medication for CMV) and Myfortic during the first visit. This was to see if my immune system could pull CMV into target range on its own. Within 4 days my CMV tested “not detected” indicating that my WBCs both recognized CMV and effectively combatted it.
My transplant nephrologist was clearly not pleased with what the infectious disease doctor did. However, the kidney has tested better consistently since that was done.
When my fourth CMV flare-up began 5 weeks ago, I contacted my transplant nephrologist and said that the prior treatments (which had been tried three times) had not successfully dealt with my CMV so, in my view, it was time to try something else.
Treatment plan for current CMV flare-up:
Temporarily discontinue Myfortic
Increase Prograf by .5 mg
No antiviral medication (Valcyte)
How has it gone?
Week 1: CMV 74; WBC 9.63
Week 2: CMV 122; WBC 6.76
Week 3: CMV 63; WBC 6.72
Week 4: CMV <35; WBC 5.89
Week 5: CMV <35; WBC 4.86
The new treatment plan has produced much lower CMV data and led to a faster resolution (defined by the nephrologist as two consecutive weeks at <35).
In the past, it’s been the third week following discontinuation of antiviral medication when the CMV flares up again. Next week’s labs will give us an idea as to whether my CMV will stay in tsrget range longer this time.
The decrease in WBC count over the past two weeks is somewhat concerning. But, overall, this treatment plan has seemed to be more effective.
They are currently running a few other tests. Once we have the results from these additional tests, we’ll hopefully get the CMV in check, I hope, for the foreseeable future.
Jayhawker